Differential Cytotoxicity of Anticancer Agents in Pre- and Post-Immortal Lymphoblastoid Cell Lines(Pharmacology)
スポンサーリンク
概要
- 論文の詳細を見る
We studied the cytotoxic effect of various anticancer agents on lymphoblastoid cell lines transformed by Epstein-Barr virus. Post-immortal N0005 (post-N0005) is an immortalized cell line derived from pre-immortal N0005 (pre-N0005) accompanied by increased telomerase activity, short-telomere, abnormal karyotypes, mutation of p53 gene, down regulation of p16/Rb and the ability to grow in soft agar medium. Compared with pre-N0005 cells, post-N0005 cells were significantly (p<0.001 by the Student t test) more resistant to the killing activity of seven DNA-modifying agents: camptothecin, etoposide, bleomycin, fluorouracil, thioguanine, melphalan and actinomycin D. However, both pre-N0005 and post-N0005 cells showed similar levels of cytotoxicity against four DNA-non-modifying agents: colchicine, paclitaxel, vincristine and methotrexate. DNA-modifying and DNA-non-modifying agents are distinguished by their different sensitivities with pre-N0005 and post-N0005. Based on these results, we propose that pre-N0005 and post-N0005 cell lines be used as a new method to assess and screen anticancer agents.
- 2005-07-01
著者
-
Sawada Kaori
Genecare (previously Agene) Research Institute
-
NODA Keisuke
GeneCare (previously AGENE) Research Institute
-
NAKAJIMA Hiroto
GeneCare (previously AGENE) Research Institute
-
SHIMBARA Naoki
GeneCare (previously AGENE) Research Institute
-
FURUICHI Yasuhiro
GeneCare (previously AGENE) Research Institute
-
SUGIMOTO Masanobu
GeneCare (previously AGENE) Research Institute
-
Sugimoto M
Genecare Research Institute
-
Sugimoto Masanobu
ジーンケア研究所
関連論文
- Terminal Telomere Repeats Are Actually Short in Telomerase-Negative Immortal Human Cells(Highlighted paper selected by Editor-in-chief)(Biochemistry/Molecular Biology)
- Differential Cytotoxicity of Anticancer Agents in Pre- and Post-Immortal Lymphoblastoid Cell Lines(Pharmacology)
- Recombinant Single-Chain Anti-idiotypic Antibody : An Effective Fungal β-1,3-Glucan Synthase Inhibitor(Microbiology)
- Identification and Characterization of a Neutralizing Monoclonal Antibody for the Epitope on HM-1 Killer Toxin
- Inhibition of β-1,3-Glucan Synthase and Cell Growth of Cryptococcus species by Recombinant Single-chain Anti-idiotypic Antibodies
- Monoclonal Antibodies and Sandwich ELISA for Quantitation of HM-1 Killer Toxin (Analytical Biochemistry)
- Round Shape Enlargement of the Yeast Spheroplast of Saccharomyces cerevisiae by HM-1 Toxin
- Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models
- Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase
- Increased Chemotherapeutic Activity of Camptothecin in Cancer Cells by siRNA-Induced Silencing of WRN Helicase(Molecular and Cell Biology)
- Innate Apoptosis of Human B Lymphoblasts Transformed by Epstein-Barr Virus : Modulation by Cellular Immortalization and Senescence
- Alanine-Scanning Mutagenesis of HM-1 Killer Toxin and the Essential Residues for Killing Activity
- Effects of Estrogenic Agents 17β-Estradiol (E2) and Bisphenol A on the Expression of RecQ DNA Helicases in Mammary Tumor MCF-7 Cells
- Modulation of the Expression of Bloom Helicase by Estrogenic Agents(Molecular and Cell Biology)
- Significant elevation of IgG anti-WRN (RecQ3 RNA/DNA helicase) antibody in systemic sclerosis
- DNA Damage Caused by Bisphenol A and Estradiol through Estrogenic Activity(Highlighted paper selected by Editor-in-chief,Analytical Biochemistry)
- Quantitative Analysis of Werner Helicase Activity Using the Single-Molecule Fluorescence Detection System MF10S(Analytical Biochemistry)
- Molecular biology of Werner syndrome
- A Case of Congenital Photosensitivity, Hair Loss, Growth Failure and Pulmonary Stenosis: Relationship with Rothmund-Thomson Syndrome
- Proteome analysis of Epstein-Barr virus-transformed B-lymphoblasts and the proteome database
- Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells
- PREVALENCE OF WERNER SYNDROME GENE MUTATIONS IN THE JAPANESE POPULATION : A GENETIC EPIDEMIOLOGICAL STUDY
- PHENOTYPES OF CELLS WITH A WRN GENE MUTATION
- Differential Effects of Cytotoxic Drugs on Mortal and Immortalized B-Lymphoblastoid Cell Lines from Normal and Werner's Syndrome Patients
- ESTIMATION OF THE PHYSICAL DISTANCE BETWEEN MAJOR GENOMIC MARKERS IN THE WERNER SYNDROME LOCUS (8p11.2-12) BY DUAL-COLOR FISH ANALYSIS
- Different buffer effects in selecting HM-1 killer toxin single-chain fragment variable anti-idiotypic antibodies